Abiopharma

📋 CHRISTOPHER CAUSEY (Director) plans to sell 1K shares of UNITED THERAPEUTICS CORPORATION (at $510.00 each, total $510K) Filed: Jan 06, 2026 | ID: 000176

📋 JULA INRIG (Officer) plans to sell 445 shares of TRAVERE THERAPEUTICS, INC. (at $37.75 each, total $17K) Filed: Jan 06, 2026 | ID: 000175

Landis John B. 🟢 acquired 40.0K shares (1 derivative) of EyePoint, Inc. (EYPT) at $17.48 Transaction Date: Jan 02, 2026 | Filing ID: 000002

📋 JAN MALCOLM (Director) plans to sell 50 shares of UNITED THERAPEUTICS CORPORATION (at $495.01 each, total $25K) Filed: Jan 06, 2026 | ID: 000174

Meyers Steve Lawrence 🟢 acquired 262.6K shares (1 derivative) of OCULAR THERAPEUTIX, INC (OCUL) at $11.82 ($2.3M) Transaction Date: Jan 02, 2026 | Filing ID: 001295

Director Braun Donald P 🟢 acquired 5.9K shares (1 derivative) of Imunon, Inc. (IMNN) at $3.95 Transaction Date: Jan 02, 2026 | Filing ID: 000607

Flammer Martina M.D. 🟡 adjusted position in 30.6K shares (3 derivative) of INSMED Inc (INSM) at $177.12 ($8.3M) Transaction Date: Jan 02, 2026 | Filing ID: 000002

Duty Stuart 🟢 acquired 40.0K shares (1 derivative) of EyePoint, Inc. (EYPT) at $17.48 Transaction Date: Jan 02, 2026 | Filing ID: 000002

Hassan Fred 🟢 acquired 40.0K shares (1 derivative) of EyePoint, Inc. (EYPT) at $17.48 Transaction Date: Jan 02, 2026 | Filing ID: 000002

Baumal Caroline 🔴 sold 3.0K shares of Apellis Pharmaceuticals, Inc. (APLS) at $25.53 Transaction Date: Jan 05, 2026 | Filing ID: 000016

Director Dentzer James E 🟢 acquired 4.4K shares (1 derivative) of Imunon, Inc. (IMNN) at $3.95 Transaction Date: Jan 02, 2026 | Filing ID: 000606

Nayak Sanjay 🟢 acquired 262.6K shares (1 derivative) of OCULAR THERAPEUTIX, INC (OCUL) at $11.82 ($2.3M) Transaction Date: Jan 02, 2026 | Filing ID: 001292

New Form 3 - Tango Therapeutics, Inc. Filed: 2026-01-06 AccNo: 0001193125-26-004401 Size: 16 KB

New Form DEFA14A - KALA BIO, Inc. Filed: 2026-01-06 AccNo: 0001829126-26-000066 Size: 15 KB

Adsett Roger 🟢 acquired 37.3K shares (1 derivative) of INSMED Inc (INSM) at $177.12 ($5.5M) Transaction Date: Jan 02, 2026 | Filing ID: 000002